Literature DB >> 28748599

A comparison of statistical methods for the study of etiologic heterogeneity.

Emily C Zabor1,2, Colin B Begg1.   

Abstract

Cancer epidemiologic research has traditionally been guided by the premise that certain diseases share an underlying etiology, or cause. However, with the rise of molecular and genomic profiling, attention has increasingly focused on identifying subtypes of disease. As subtypes are identified, it is natural to ask the question of whether they share a common etiology or in fact arise from distinct sets of risk factors. In this context, epidemiologic questions of interest include (1) whether a risk factor of interest has the same effect across all subtypes of disease and (2) whether risk factor effects differ across levels of each individual tumor marker of which the subtypes are comprised. A number of statistical models have been proposed to address these questions. In an effort to determine the similarities and differences among the proposed methods, and to identify any advantages or disadvantages, we use a simplified data example to elucidate the interpretation of model parameters and available hypothesis tests, and we perform a simulation study to assess bias in effect size, type I error, and power. The results show that when the number of tumor markers is small enough that the cross-classification of markers can be evaluated in the traditional polytomous logistic regression framework, then the statistical properties are at least as good as the more complex modeling approaches that have been proposed. The potential advantage of more complex methods is in the ability to accommodate multiple tumor markers in a model of reduced parametric dimension.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cancer epidemiology; disease subtypes; etiologic heterogeneity

Mesh:

Substances:

Year:  2017        PMID: 28748599      PMCID: PMC5677262          DOI: 10.1002/sim.7405

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  16 in total

Review 1.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Authors:  Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward Giovannucci
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

2.  Detecting and exploiting etiologic heterogeneity in epidemiologic studies.

Authors:  Colin B Begg; Emily C Zabor
Journal:  Am J Epidemiol       Date:  2012-08-24       Impact factor: 4.897

3.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors:  T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

4.  Statistical analysis of molecular epidemiology studies employing case-series.

Authors:  C B Begg; Z F Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994-03       Impact factor: 4.254

5.  Analysis of cohort studies with multivariate and partially observed disease classification data.

Authors:  Nilanjan Chatterjee; Samiran Sinha; W Ryan Diver; Heather Spencer Feigelson
Journal:  Biometrika       Date:  2010-06-30       Impact factor: 2.445

6.  A conceptual and methodological framework for investigating etiologic heterogeneity.

Authors:  Colin B Begg; Emily C Zabor; Jonine L Bernstein; Leslie Bernstein; Michael F Press; Venkatraman E Seshan
Journal:  Stat Med       Date:  2013-07-16       Impact factor: 2.373

7.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

8.  Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.

Authors:  Louise A Brinton; Ashley S Felix; D Scott McMeekin; William T Creasman; Mark E Sherman; David Mutch; David E Cohn; Joan L Walker; Richard G Moore; Levi S Downs; Robert A Soslow; Richard Zaino
Journal:  Gynecol Oncol       Date:  2013-02-26       Impact factor: 5.482

9.  Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.

Authors:  Gregory J Riely; Mark G Kris; Daniel Rosenbaum; Jenifer Marks; Allan Li; Dhananjay A Chitale; Khedoudja Nafa; Elyn R Riedel; Meier Hsu; William Pao; Vincent A Miller; Marc Ladanyi
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

10.  Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factors.

Authors:  Joellen M Schildkraut; Edwin S Iversen; Lucy Akushevich; Regina Whitaker; Rex C Bentley; Andrew Berchuck; Jeffrey R Marks
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-05       Impact factor: 4.254

View more
  6 in total

Review 1.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

Review 2.  Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.

Authors:  Shuji Ogino; Jonathan A Nowak; Tsuyoshi Hamada; Amanda I Phipps; Ulrike Peters; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Marios Giannakis; Wendy S Garrett; Mingyang Song
Journal:  Gut       Date:  2018-02-06       Impact factor: 23.059

Review 3.  The clinical trajectory of emerging bipolar disorder among the high-risk offspring of bipolar parents: current understanding and future considerations.

Authors:  A Duffy; C Vandeleur; N Heffer; M Preisig
Journal:  Int J Bipolar Disord       Date:  2017-11-22

4.  Validity of a method for identifying disease subtypes that are etiologically heterogeneous.

Authors:  Emily C Zabor; Venkatraman E Seshan; Shuang Wang; Colin B Begg
Journal:  Stat Methods Med Res       Date:  2021-07-28       Impact factor: 2.494

5.  Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology.

Authors:  Shuji Ogino; Iny Jhun; Douglas A Mata; Thing Rinda Soong; Tsuyoshi Hamada; Li Liu; Reiko Nishihara; Marios Giannakis; Yin Cao; JoAnn E Manson; Jonathan A Nowak; Andrew T Chan
Journal:  NPJ Precis Oncol       Date:  2017-12-06

6.  A mixed-model approach for powerful testing of genetic associations with cancer risk incorporating tumor characteristics.

Authors:  Haoyu Zhang; Ni Zhao; Thomas U Ahearn; William Wheeler; Montserrat García-Closas; Nilanjan Chatterjee
Journal:  Biostatistics       Date:  2021-10-13       Impact factor: 5.899

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.